-
Rapid Micro Biosystems reports record Q4 2025 revenue of $11.3 million
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
Rapid Micro Biosystems, Inc. (RPID) Misses Q3 EPS by 1c
-
Stifel Reiterates Buy Rating on Rapid Micro Biosystems Inc (RPID)
-
Rapid Micro Biosystems, Inc. (RPID) Misses Q2 EPS by 1c ; Offers Guidance
-
Rapid Micro Biosystems secures $45 million loan from Trinity Capital
-
Lake Street Capital Markets Starts Rapid Micro Biosystems Inc (RPID) at Buy
-
Rapid Micro Biosystems (RPID) Appoints Dafni Bika to its Board
-
Rapid Micro Biosystems, Inc. (RPID) Misses Q1 EPS by 2c ; Offers Guidance
-
KeyBanc Reiterates Overweight Rating on Rapid Micro Biosystems Inc (RPID)
-
Rapid Micro Biosystems, Inc. (RPID) Misses Q4 EPS by 1c ; Offers Guidance
-
KeyBanc Starts Rapid Micro Biosystems Inc (RPID) at Overweight
-
Rapid Micro Biosystems (RPID) Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
-
Rapid Micro Biosystems, Inc. (RPID) Misses Q3 EPS by 1c ; Offers Guidance
-
Rapid Micro Biosystems, Inc. (RPID) Misses Q2 EPS by 1c ; Offers Guidance

